other material
confidence high
sentiment neutral
materiality 0.55
NeOnc raises $1.6M placement; partners CBCC for India GBM trial
NEONC TECHNOLOGIES HOLDINGS, INC.
- Private placement gross proceeds ~$1.6M at $16/share for working capital.
- Strategic partnership with CBCC Global Research to enroll patients at 30 FDA-compliant sites in India.
- Partnership targets Phase 2a NEO100-01 GBM trial; enrollment completion expected this year, readout 6-8 months after.
- Financing is unregistered under Rule 506(b) to accredited investors.